We observed that the level of CCDC19 protein expression was significantly correlated with overall survival time, as patients with lower levels of CCDC19 expression had poorer survival (Fig. 1C) than those with greater CCDC19 expression (P = 0.012) in NSCLC or squamous cell carcinoma (P = 0.075), or adenocarcinoma (P = 0.026). The gene discussed is CFAP45; the disease is squamous cell carcinoma.